Comparison characteristics of Supraclavicular block with bupivacaine 0.5% plus dexmedetomidine and granisetron and Magnesium sulphate in upper extremity orthopedic surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N125

Enrollment

105

Registered

2019-12-13

Start date

2019-09-23

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper extremity fractures. Unspecified fracture of forearm

Interventions

Intervention 1: Intervention group 1: We will inject 25 milliliter Bupivacaine 0.5% plus 1 micro gram in kilogram Dexmedetomidine. Intervention 2: Intervention group 2: We will inject 25 milliliter Bu

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Both of gender 20 to 70 years ASA class I and II Candidate for orthopedic surgery of upper limb Body mass index lower than 35

Exclusion criteria

Exclusion criteria: There is more than one body fracture or surgery Coagulation diseases and disorders in PT,PTT, INR Psychological problems Pregnancy Neurological disorders in the hand

Design outcomes

Primary

Measure	Time frame
Duration of motor block. Timepoint: Every 5 minute. Method of measurement: Physical examination.;Duration of Sensory block. Timepoint: Every 1 minute. Method of measurement: Physical examination.;Pain. Timepoint: Recovery and 2 and 4 and 8 and 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Behnam Mahmodie

Arak University of Medical Sciences

mahmodie@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026